Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Patients With Locally Advanced or Metastatic Melanoma

NCT03013101 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Advanced Melanoma
Metastatic Melanoma

Interventions

BIOLOGICAL: humanized anti-PD-1 monoclonal antibody toripalimab

Sponsor

Shanghai Junshi Bioscience Co., Ltd.